Preliminary results of metronomic capecitabine treatment in advanced hepatocellular carcinoma (HCC)

被引：0
|
作者：
Brandi, G.
Fanello, S.
Piscaglia, F.
Falanga, A.
Balducci, D.
Pantaleo, M. A.
Muscolo, P.
Derenzini, E.
Bolondi, L.
Biasco, G.
机构：
来源：
ANNALS OF ONCOLOGY | 2007年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：12 / 13
页数：2
相关论文
共 50 条
  • [1] Metronomic capecitabine in the advanced patients with hepatocellular carcinoma (HCC): Preliminary results
    Brandi, G.
    Fanello, S.
    Piscaglia, F.
    Falanga, A.
    Bolondi, L.
    Flori, S.
    Derenzini, E.
    Palassini, E.
    Fedele, M.
    Biasco, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [2] EFFICACY AND TOXICITY OF METRONOMIC CAPECITABINE IN ADVANCED HEPATOCELLULAR CARCINOMA
    Farrag, A.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S391 - S391
  • [3] Role of metronomic capecitabine in advanced hepatocellular carcinoma.
    Mateen, Abdul
    Adil, Allah Rakha
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [4] Metronomic Capecitabine in Advanced Hepatocellular Carcinoma Patients: A Phase II Study
    Brandi, Giovanni
    de Rosa, Francesco
    Agostini, Valentina
    di Girolamo, Stefania
    Andreone, Pietro
    Bolondi, Luigi
    Serra, Carla
    Sama, Claudia
    Golfieri, Rita
    Gramenzi, Annagiulia
    Cucchetti, Alessandro
    Pinna, Antonio Daniele
    Trevisani, Franco
    Biasco, Guido
    ONCOLOGIST, 2013, 18 (12): : 1256 - 1257
  • [5] Long-lasting response with metronomic capecitabine in advanced hepatocellular carcinoma
    Ballardini, Pierluigi
    Marri, Ivan
    Margutti, Guido
    Aliberti, Camillo
    Benea, Giorgio
    Manfredini, Roberto
    TUMORI JOURNAL, 2010, 96 (05): : 768 - 770
  • [6] Capecitabine for treatment of advanced hepatocellular carcinoma
    von Delius, S.
    Lersch, C.
    Mayr, M.
    Stock, K.
    Schulte-Frohlinde, E.
    Schmid, R. M.
    Eckel, F.
    HEPATO-GASTROENTEROLOGY, 2007, 54 (80) : 2310 - 2314
  • [7] Combination of capecitabine, oxaliplatin with bevacizumab in treatment of advanced hepatocellular carcinoma (HCC): A phase II study
    Sun, W.
    Haller, D. G.
    Mykulowycz, K.
    Rosen, M.
    Soulen, M.
    Capparo, M.
    Faust, T.
    Giantonia, B.
    Olthoff, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [8] Metronomic oral cyclophosphamide & low dose nivolumab for advanced hepatocellular carcinoma (HCC).
    Chen, Jo-Pai
    Kao, Tsui-Mai
    Hsueh, Fu-Jen
    Lu, Wei-Chen
    Ma, Wei-li
    Wu, Hsu
    Chiang, Keng-Man
    Chen, Hsing-wu
    Kuo, Sung-Hsin
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [9] Systemic therapies in elderly patients with advanced hepatocellular carcinoma: Do not forget metronomic capecitabine
    Wilhelmi, Markus
    EJSO, 2021, 47 (08): : 2208 - 2208
  • [10] Sustained complete response of advanced hepatocellular carcinoma with metronomic capecitabine: a report of three cases
    Brandi, Giovanni
    Venturi, Michela
    De Lorenzo, Stefania
    Garuti, Francesca
    Frega, Giorgio
    Palloni, Andrea
    Garajova, Ingrid
    Abbati, Francesca
    Saccoccio, Gioconda
    Golfieri, Rita
    Pantaleo, Maria Abbondanza
    Barbera, Maria Aurelia
    CANCER COMMUNICATIONS, 2018, 38
12345